NRX Pharmaceuticals, Inc. Share Price
NASDAQ: NRXP | Micro CapNRX Pharmaceuticals, Inc. Stock Performance
Open $3.51 | Prev. Close $3.10 | Circuit Range N/A |
Day Range $3.38 - $4.14 | Year Range $1.64 - $5.05 | Volume 1,59,656 |
Average Traded $3.71 |
NRX Pharmaceuticals, Inc. Share Price Today
As of 10 August 2026, NRX Pharmaceuticals, Inc.'s share price is $3.57. The stock opened at $3.51, compared to its previous close of $3.10. During today's trading session, NRX Pharmaceuticals, Inc.'s share price traded between $3.38 and $4.14, with an average price of $3.76. Over the past 52 weeks, the stock has recorded a high of $5.05 and a low of $1.64. In terms of performance, NRX Pharmaceuticals, Inc.'s share price has risen by 91.94% over the last six months and is up 54.21% on a year-on-year basis.
NRX Pharmaceuticals, Inc. Share Price Chart
NRX Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $76.40M | PE Ratio (TTM) -2.66 | Dividend Yield N/A |
EPS (TTM) $-1.34 | Revenue (TTM) $1.23M | Return On Equity (TTM) 179.59% |
Profit Margin -2336.49% | Debt to Equity -1.79 | Quarterly Earnings Growth YoY -262.91% |
NRX Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
NRX Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $3.18 | $3.58 | +13.31% |
Jul 2026 | $4.07 | $3.15 | -22.94% |
Jun 2026 | $4.57 | $4.09 | -7.58% |
May 2026 | $2.93 | $4.43 | +48.16% |
Apr 2026 | $2.20 | $2.99 | +40.05% |
Mar 2026 | $1.81 | $2.13 | +14.78% |
Feb 2026 | $2.13 | $1.86 | -11.64% |
Jan 2026 | $2.68 | $2.10 | -21.75% |
Dec 2025 | $2.42 | $2.69 | +10.25% |
Nov 2025 | $3.05 | $2.44 | -21.42% |
Oct 2025 | $3.26 | $3.10 | -5.91% |
Sep 2025 | $2.33 | $3.30 | +42.55% |
NRXP Share Price FAQs
What is NRX Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of NRX Pharmaceuticals, Inc. stock?
What is NRXP's market capitalisation today?
What is NRXP's net income for the last quarter?
What is the 5 year returns of NRXP?
What is the high & low stock price of NRXP today?
Can I buy NRXP shares in India?